Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab

PURPOSE: To report the visual and anatomic outcomes in eyes with macular oedema (MO) secondary to central retinal vein occlusion (CRVO) that were switched from either intravitreal bevacizumab or ranibizumab to intravitreal aflibercept. METHODS: Two-center retrospective chart review. Eyes with MO sec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eye (Lond)
Main Authors: Papakostas, T D, Lim, L, van Zyl, T, Miller, J B, Modjtahedi, B S, Andreoli, C M, Wu, D, Young, L H, Kim, I K, Vavvas, D G, Esmaili, D D, Husain, D, Eliott, D, Kim, L A
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4709525/
https://ncbi.nlm.nih.gov/pubmed/26449196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2015.175
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados